Yamamoto Daisuke, Takai Shinji, Miyazaki Mizuo
Biomedical Computation Center, Osaka Medical College, 2-7 Daigakuchou, Takatsuki, Osaka, Japan.
Biochem Biophys Res Commun. 2007 Mar 23;354(4):981-4. doi: 10.1016/j.bbrc.2007.01.088. Epub 2007 Jan 25.
To characterize the inhibitory specificity of angiotensin converting enzyme (ACE) inhibitors for matrix metalloproteinase 9 (MMP-9) activity, molecular modeling of these complex was performed referring the recent X-ray structure analyses using lisinopril as an ACE inhibitor. Two interaction modes differing in the orientation of the inhibitor on the active site were identified. Lisinopril was effectively stabilized by specific hydrogen bonds and hydrophobic interactions in the active site of MMP-9, and its hydrophobic group appeared to interact preferentially with the S1 site compared with the S1' site. These findings showed that ACE inhibitors could become important seeds for cardiovascular protection and the development of MMP inhibitors.
为了表征血管紧张素转换酶(ACE)抑制剂对基质金属蛋白酶9(MMP-9)活性的抑制特异性,参照最近使用赖诺普利作为ACE抑制剂的X射线结构分析,对这些复合物进行了分子建模。确定了抑制剂在活性位点上方向不同的两种相互作用模式。赖诺普利通过MMP-9活性位点中的特定氢键和疏水相互作用有效地稳定下来,并且与S1'位点相比,其疏水基团似乎优先与S1位点相互作用。这些发现表明,ACE抑制剂可能成为心血管保护和MMP抑制剂开发的重要种子。